TFS
Thoroughbred Financial Services Portfolio holdings
AUM
$1.43B
1-Year Return
27.42%
This Quarter Return
+5.66%
1 Year Return
+27.42%
3 Year Return
+117.49%
5 Year Return
+175.64%
10 Year Return
–
AUM
$1.49B
AUM Growth
+$455M
(+44%)
Cap. Flow
+$408M
Cap. Flow
% of AUM
27.31%
Top 10 Holdings %
Top 10 Hldgs %
27.67%
Holding
650
New
192
Increased
381
Reduced
38
Closed
17
Top Buys
| 1 |
Apple
AAPL
|
$16.1M |
| 2 |
Escalade
ESCA
|
$15.5M |
| 3 |
Microsoft
MSFT
|
$13.5M |
| 4 |
NVIDIA
NVDA
|
$11.4M |
| 5 |
Amazon
AMZN
|
$9.72M |
Top Sells
| 1 |
Tesla
TSLA
|
$977K |
| 2 |
Tarsus Pharmaceuticals
TARS
|
$762K |
| 3 |
UiPath
PATH
|
$709K |
| 4 |
Fomento Económico Mexicano
FMX
|
$689K |
| 5 |
Coca-Cola
KO
|
$670K |
Sector Composition
| 1 | Technology | 26.93% |
| 2 | Consumer Discretionary | 8.56% |
| 3 | Financials | 7.45% |
| 4 | Healthcare | 6.29% |
| 5 | Industrials | 4.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Vanguard Small-Cap Growth ETF
VBK
$20.4B
| $204K | 0.01% |
+816
| New | +$204K |
|
602
Boston Scientific
BSX
$159B
| $203K | 0.01% |
+2,649
| New | +$203K |
|
603
ING
ING
$71B
| $203K | 0.01% |
+11,898
| New | +$203K |
|
604
Kinsale Capital Group
KNSL
$10.6B
| $203K | 0.01% |
+528
| New | +$203K |
|
605
Dorman Products
DORM
$5B
| $202K | 0.01% |
+2,219
| New | +$202K |
|
606
Ford
F
$46.7B
| $202K | 0.01% |
16,130
+1,192
| +8% | +$14.9K |
|
607
Houlihan Lokey
HLI
$13.9B
| $201K | 0.01% |
+1,495
| New | +$201K |
|
608
IDEX
IEX
$12.4B
| $201K | 0.01% |
+1,001
| New | +$201K |
|
609
Nuveen ESG Mid-Cap Growth ETF
NUMG
$409M
| $201K | 0.01% |
+4,815
| New | +$201K |
|
610
iShares MSCI ACWI ETF
ACWI
$22.1B
| $200K | 0.01% |
+1,783
| New | +$200K |
|
611
eBay
EBAY
$42.3B
| $200K | 0.01% |
+3,736
| New | +$200K |
|
612
Amcor
AMCR
$19.1B
| $183K | 0.01% |
+18,712
| New | +$183K |
|
613
CEL-SCI Corp
CVM
$72.1M
| $158K | 0.01% |
4,559
+2,667
| +141% | +$92.4K |
|
614
Barclays
BCS
$69.1B
| $149K | 0.01% |
+13,963
| New | +$149K |
|
615
Community Health Systems
CYH
$409M
| $131K | 0.01% |
39,187
+16,600
| +73% | +$55.5K |
|
616
Cardiff Oncology
CRDF
$145M
| $116K | 0.01% |
+52,375
| New | +$116K |
|
617
Haleon
HLN
$43.8B
| $108K | 0.01% |
+13,102
| New | +$108K |
|
618
Larimar Therapeutics
LRMR
$337M
| $94K | 0.01% |
+13,100
| New | +$94K |
|
619
Microvision
MVIS
$334M
| $93K | 0.01% |
88,670
+20,000
| +29% | +$21K |
|
620
Warner Bros
WBD
$30B
| $84K | 0.01% |
11,376
+65
| +0.6% | +$480 |
|
621
Cemex
CX
$13.7B
| $81K | 0.01% |
+12,755
| New | +$81K |
|
|
EAD
622
Allspring Income Opportunities Fund
EAD
$421M
| $72K | ﹤0.01% |
+10,930
| New | +$72K |
|
623
Ginkgo Bioworks
DNA
$659M
| $70K | ﹤0.01% |
+5,250
| New | +$70K |
|
624
Microbot Medical
MBOT
$178M
| $53K | ﹤0.01% |
+52,250
| New | +$53K |
|
625
D-Wave Quantum
QBTS
$5.26B
| $45K | ﹤0.01% |
+40,000
| New | +$45K |
|